Patient Support Programs
Alio, a Calian Company, partners with pharmaceutical companies to design and implement comprehensive patient support programs (PSPs) that enhance the patient's experience throughout their treatment journey.
Focused on creating the best experience for patients, caregivers and the health care industry as a whole.
Our dedicated team designs customized PSPs that connect all parties using a targeted approach to exceed industry benchmarks while delivering a higher-quality patient experience.
We have unique and proprietary PSP workflow-automation software and systems to ensure excellent quality control, provide significant cost efficiencies and enable a higher volume of patient interactions. As a result, we can provide in-home services at about the same cost as in-clinic, ensuring better outcomes for patients.
Adherence
Adherence to the prescribed medication schedule is extremely important in helping patients achieve a positive treatment outcome. Our Stay on Therapy program helps patients remain in control of their treatment through guidance, education and accountability. We believe that patient empowerment through holistic disease management and patient-centric services is the future of adherence programs.
The Stay on Therapy program helps patients comply with their prescribed treatment by offering:
- Dedicated care coordinators to facilitate prescriptions, refills and reimbursement
- Calls, emails and SMS to remind patients of:
- Physician visits
- Medication refills
- Dosing schedules
- Educational support
Real World Evidence
Real world evidence (RWE) is the clinical evidence concerning the usage, benefits and risks of marketed pharmaceutical products in clinical practice. RWE is derived from an analysis of real world data assembled about a product’s use in the “real world”, collected outside the controls and limitations of conventional randomized clinical trials. RWE fulfills the need for broader information on real-world effectiveness and safety that will impact the reimbursement and utilization of new medications as driven by regulators, public and private payers, prescribers and manufacturers.
Data about real-world patient experience has the potential to improve the quality and delivery of medical care, reduce overall costs and improve outcomes. These data help fill the knowledge gap between clinical trials and actual clinical practice.
In partnership with Allphase Clinical Research, a Calian Company, we offer custom-designed qualitative and quantitative real world evidence (RWE) data collection as part of our patient programs.
